Associated Papers
IP-SNPs-seq links noncoding risk alleles to lineage transcription factor programs in prostate cancer.
Xu W et al.
Cellular and Molecular Life Sciences : Cmls, 2025
41359169 (PubMed )
Supplement: 18_2025_5964_MOESM5_ESM.xlsx › Figure_4e
TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era.
Landsburg DJ et al.
Blood Advances, 2023
37851898 (PubMed )
Supplement: BLOODA_ADV-2023-011384-mmc1.pdf
FOXA1 regulates alternative splicing in prostate cancer.
Del Giudice M et al.
Cell Reports, 2022
36170835 (PubMed )
Supplement: mmc2.xlsx › primary_PC
Systematic analysis reveals molecular characteristics of ERG-negative prostate cancer.
Xiao Q et al.
Scientific Reports, 2018
30150711 (PubMed )
Supplement: 41598_2018_30325_MOESM2_ESM.xlsx › SuppTable1-Sample_Group
Influence of 17q gain and promoter polymorphisms on mRNA expression of somatostatin receptor type 2 in neuroblastoma.
Simi L et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2007
Select a paper to view details